Knockdown of LARP1 in OVCAR3 and IGROV-1 lines, and in cervical cancer-derived HeLa cells, resulted in a significant decrease in CD133+ cell populations (Figure 6A and B; Supplementary Figure S6B). This evidence concerns the gene LARP1 and cervical cancer.